{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:06:22Z","timestamp":1787785582106,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04567-x","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:46:04Z","timestamp":1771227964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RET germline mutations drive tumorigenesis but not tumor aggressiveness in MEN 2"],"prefix":"10.1007","volume":"91","author":[{"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"4567_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"S.A. Wells Jr, S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, Waguespack; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma, revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25, 567\u2013610 (2015)","journal-title":"Thyroid"},{"key":"4567_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/humu.23430","volume":"39","author":"A Machens","year":"2018","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Genotype-specific progression of hereditary medullary thyroid cancer. Hum. Mutat. 39, 860\u2013869 (2018)","journal-title":"Hum. Mutat."},{"key":"4567_CR3","doi-asserted-by":"publisher","first-page":"e240038","DOI":"10.1530\/ERC-24-0038","volume":"31","author":"A Machens","year":"2024","unstructured":"A. Machens, K. Lorenz, F. Weber, T. Brandenburg, D. F\u00fchrer-Sakel, H. Dralle, Genotype-specific development of MEN 2 constituent components in 683 RET carriers. Endocr. Relat. Cancer. 31, e240038 (2024)","journal-title":"Endocr. Relat. Cancer"},{"key":"4567_CR4","doi-asserted-by":"publisher","first-page":"e240187","DOI":"10.1530\/ERC-24-0187","volume":"32","author":"TJ Walker","year":"2024","unstructured":"T.J. Walker, L.M. Mulligan, Cellular mechanisms of RET receptor dysfunction in multiple endocrine neoplasia 2. Endocr. Relat. Cancer. 32, e240187 (2024)","journal-title":"Endocr. Relat. Cancer"},{"key":"4567_CR5","first-page":"233","volume":"60","author":"I Schuffenecker","year":"1997","unstructured":"I. Schuffenecker, N. Ginet, D. Goldgar, C. Eng, B. Chambe, A. Boneu, C. Houdent, D. Pallo, M. Schlumberger, C. Thivolet, G.M. Lenoir, Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma. Le Groupe d\u2019 Etude des Tumeurs a Calcitonine. Am. J. Hum. Genet. 60, 233\u2013237 (1997)","journal-title":"Am. J. Hum. Genet."},{"key":"4567_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","volume":"259","author":"M Brauckhoff","year":"2014","unstructured":"M. Brauckhoff, A. Machens, K. Lorenz, T. Bj\u00f8ro, J.E. Varhaug, H. Dralle, Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective. Ann. Surg. 259, 800\u2013806 (2014)","journal-title":"Ann. Surg."},{"key":"4567_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/jc.2017-01884","volume":"103","author":"F Raue","year":"2018","unstructured":"F. Raue, H. Dralle, A. Machens, T. Bruckner, K. Frank-Raue, Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium. J. Clin. Endocrinol. Metab. 103, 235\u2013243 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR8","doi-asserted-by":"crossref","unstructured":"F. Castinetti, S.G. Waguespack, A. Machens, S. Uchino, K. Hasse-Lazar, G. Sanso, T. Else, S. Dvorakova, X.P. Qi, R. Elisei, A.L. Maia, J. Glod, D.M. Louren\u00e7o Jr, N. Valdes, J. Mathiesen, N. Wohllk, T.R. Bandgar, D. Drui, M. Korbonits, M.R. Druce, C. Brain, T. Kurzawinski, A. Patocs, M.J. Bugalho, A. Lacroix, P. Caron, P. Fainstein-Day, F. Borson Chazot, M. Klein, T.P. Links, C. Letizia, L. Fugazzola, O. Chabre, L. Canu, R. Cohen, A. Tabarin, A. Spehar Uroic, D. Maiter, S. Laboureau, C. Mian, M. Peczkowska, F. Sebag, T. Brue, D. Mirebeau-Prunier, L. Leclerc, B. Bausch, A. Berdelou, A. Sukurai, P. Vlcek, J. Krajewska, M. Barontini, C. Vaz Ferreira Vargas, C. Valerio, L. Ceolin, S. Akshintala, A. Hoff, C. Godballe, B. Jarzab, C. Jimenez, C. Eng, T. Imai, M. Schlumberger, E. Grubbs, H. Dralle, H.P. Neumann, E. Baudin, Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol. 7, 213\u2013220 (2019)","DOI":"10.1016\/S2213-8587(18)30336-X"},{"key":"4567_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"C. Eng, D. Clayton, I. Schuffenecker, G. Lenoir, G. Cote, R.F. Gagel, H.K. van Amstel, C.J. Lips, I. Nishisho, S.I. Takai, D.J. Marsh, B.G. Robinson, K. Frank-Raue, F. Raue, F. Xue, W.W. Noll, C. Romei, F. Pacini, M. Fink, B. Niederle, J. Zedenius, M. Nordenskj\u00f6ld, P. Komminoth, G.N. Hendy, H. Gharib, S.N. Thibodeau, A. Lacroix, A. Frilling, B.A.J. Ponder, L.M. Mulligan, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. J. Am. Med. Assoc. 276, 1575\u20131579 (1996)","journal-title":"J. Am. Med. Assoc."},{"key":"4567_CR10","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T.J. van Vroonhoven, H.D. Roeher, R.A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, H. Dralle; European Multiple Endocrine Neoplasia (EUROMEN) Study Group, Early malignant progression of hereditary medullary thyroid cancer. N. Engl. J. Med. 349, 1517\u20131525 (2003)","journal-title":"New. Engl. J. Med."},{"key":"4567_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJMoa043999","volume":"353","author":"MA Skinner","year":"2005","unstructured":"M.A. Skinner, J.A. Moley, W.G. Dilley, K. Owzar, M.K. Debenedetti, S.A. Wells Jr, Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N . Engl. J. Med. 353, 1105\u20131113 (2005)","journal-title":"New. Engl. J. Med."},{"key":"4567_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12020-022-03273-8","volume":"80","author":"A Machens","year":"2023","unstructured":"A. Machens, K. Lorenz, E.M. Huessler, A. Stang, F. Weber, H. Dralle, Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines. Endocrine. 80, 100\u2013110 (2023)","journal-title":"Endocrine"},{"key":"4567_CR13","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","volume":"262","author":"JF Moley","year":"2015","unstructured":"J.F. Moley, M. Skinner, W.E. Gillanders, T.C. Lairmore, K.J. Rowland, A.L. Traugott, L.X. Jin, S.A. Wells Jr, Management of the parathyroid glands during preventive thyroidectomy in patients with multiple endocrine neoplasia type 2. Ann. Surg. 262, 641\u2013646 (2015)","journal-title":"Ann. Surg."},{"key":"4567_CR14","doi-asserted-by":"publisher","first-page":"e240139","DOI":"10.1530\/ERC-24-0139","volume":"31","author":"F Castinetti","year":"2024","unstructured":"F. Castinetti, C. Eng, Genotype\/phenotype correlations in multiple endocrine neoplasia type 2. Endocr. Relat. Cancer. 31, e240139 (2024)","journal-title":"Endocr. Relat. Cancer"},{"key":"4567_CR15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2017-00317","volume":"102","author":"RK Voss","year":"2017","unstructured":"R.K. Voss, L. Feng, J.E. Lee, N.D. Perrier, P.H. Graham, S.M. Hyde, F. Nieves-Munoz, M.E. Cabanillas, S.G. Waguespack, G.J. Cote, R.F. Gagel, E.G. Grubbs, Medullary thyroid carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness. J. Clin. Endocrinol. Metab. 102, 2807\u20132813 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR16","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1210\/jc.2019-00516","volume":"104","author":"F Raue","year":"2019","unstructured":"F. Raue, T. Bruckner, K. Frank-Raue, Long-term outcomes and aggressiveness of hereditary medullary thyroid carcinoma: 40 years of experience at one center. J. Clin. Endocrinol. Metab. 104, 4264\u20134272 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ejso.2020.09.004","volume":"47","author":"A Machens","year":"2021","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation. Eur. J. Surg. Oncol. 47, 920\u2013923 (2021)","journal-title":"Eur. J. Surg. Oncol."},{"key":"4567_CR18","doi-asserted-by":"publisher","first-page":"e2968","DOI":"10.1210\/clinem\/dgab214","volume":"106","author":"A Machens","year":"2021","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Exceptionality of distant metastasis in node-negative hereditary and sporadic medullary thyroid cancer: lessons learned. J. Clin. Endocrinol. Metab. 106, e2968\u2013e2979 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR19","doi-asserted-by":"publisher","first-page":"e3582","DOI":"10.1210\/clinem\/dgab326","volume":"106","author":"F Raue","year":"2021","unstructured":"F. Raue, T. Bruckner, R. Frank-Raue, Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 106, e3582\u2013e3591 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-642-84749-3_9","volume":"25","author":"H Dralle","year":"1992","unstructured":"H. Dralle, G.F. Scheumann, J. Kotzerke, E.G. Brabant, Surgical management of MEN 2. Recent. Results Cancer Res. 25, 167\u2013195 (1992)","journal-title":"Recent. Results Cancer Res."},{"key":"4567_CR21","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1210\/jc.2015-1689","volume":"100","author":"A Machens","year":"2015","unstructured":"A. Machens, H. Dralle, Therapeutic effectiveness of screening for multiple endocrine neoplasia type 2A. J. Clin. Endocrinol. Metab. 100, 2539\u20132545 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/EJE-21-1086","volume":"186","author":"A Machens","year":"2022","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Sex differences in MEN 2A penetrance and expression according to parental inheritance. Eur. J. Endocrinol. 186, 469\u2013476 (2022)","journal-title":"Eur. J. Endocrinol."},{"key":"4567_CR23","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"M.L. Brandi, R.F. Gagel, A. Angeli, J.P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R.G. Gheri, A. Libroia, C.J. Lips, G. Lombardi, M. Mannelli, F. Pacini, B.A. Ponder, F. Raue, B. Skogseid, G. Tamburrano, R.V. Thakker, N.W. Thompson, P. Tomassetti, F. Tonelli, S.A. Wells Jr, S.J. Marx, Guidelines for diagnosis and therapy of MEN type 1 and type 2. J. Clin. Endocrinol. Metab. 86, 5658\u20135671 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR24","doi-asserted-by":"crossref","unstructured":"R.T. Kloos, C. Eng, D.B. Evans, G.L. Francis, R.F. Gagel, H. Gharib, J.F. Moley, F. Pacini, M.D. Ringel, M. Schlumberger, S.A. Wells Jr, Medullary thyroid cancer: management guidelines of the American Thyroid Association. American Thyroid Association Guidelines Task Force. Thyroid 19, 565\u2013612 (2009)","DOI":"10.1089\/thy.2008.0403"},{"key":"4567_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12020-020-02453-8","volume":"70","author":"N Rajan","year":"2020","unstructured":"N. Rajan, T. Khanal, M.D. Ringel, Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications. Endocrine. 70, 24\u201335 (2020)","journal-title":"Endocrine"},{"key":"4567_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"E.L. Kaplan, P. Meier, Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457\u2013481 (1958)","journal-title":"J. Am. Stat. Assoc."},{"key":"4567_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"R. Peto, M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, S.V. Howard, N. Mantel, K. McPherson, J. Peto, P.G. Smith, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br. J. Cancer. 35, 1\u201339 (1977)","journal-title":"Br. J. Cancer"},{"key":"4567_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-132-7-200004040-00028","volume":"132","author":"A Machens","year":"2000","unstructured":"A. Machens, C. Behrmann, H. Dralle, Chemoembolization of liver metastases from medullary thyroid carcinoma. Ann. Intern. Med. 132, 596\u2013597 (2000)","journal-title":"Ann. Intern. Med."},{"key":"4567_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12020-022-03073-0","volume":"77","author":"A Machens","year":"2022","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutations. Endocrine. 77, 160\u2013167 (2022)","journal-title":"Endocrine"},{"key":"4567_CR30","doi-asserted-by":"publisher","first-page":"109756","DOI":"10.1016\/j.ejso.2025.109756","volume":"51","author":"A Machens","year":"2025","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Incidence and distribution of neck node metastases in hereditary versus sporadic medullary thyroid cancer at basal calcitonin serum levels\u2009\u2264\u2009100 pg\/ml: 30-year experience. Eur. J. Surg. Oncol. 51, 109756 (2025)","journal-title":"Eur. J. Surg. Oncol."},{"key":"4567_CR31","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1002\/bjs.10746","volume":"105","author":"A Machens","year":"2018","unstructured":"A. Machens, M. Elwerr, K. Lorenz, F. Weber, H. Dralle, Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations. Br. J. Surg. 105, e150\u2013e157 (2018)","journal-title":"Br. J. Surg."},{"key":"4567_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/bjs.10856","volume":"105","author":"FP Prete","year":"2018","unstructured":"F.P. Prete, T. Abdel-Aziz, C. Morkane, C. Brain, T.R. Kurzawinski, MEN2 in Children UK Collaborative Group. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Br. J. Surg. 105, 1319\u20131327 (2018)","journal-title":"Br. J. Surg."},{"key":"4567_CR33","doi-asserted-by":"publisher","first-page":"e3559","DOI":"10.1210\/clinem\/dgaf171","volume":"110","author":"R Casalini","year":"2025","unstructured":"R. Casalini, C. Romei, V. Bottici, V. Cappagli, V. Tascini, A. Matrone, A. Prete, R. Ciampi, T. Ramone, R. Elisei, Prevalence and genetics of de novo MEN2 syndromes. J. Clin. Endocrinol. Metab. 110, e3559\u2013e3565 (2025)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s12020-023-03459-8","volume":"82","author":"A Machens","year":"2023","unstructured":"A. Machens, K. Lorenz, F. Weber, T. Brandenburg, D. F\u00fchrer-Sakel, H. Dralle, Clinical presentation of MEN 2A in index vs. non-index patients. Endocrine. 82, 450\u2013455 (2023)","journal-title":"Endocrine"},{"key":"4567_CR35","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s12020-025-04344-2","volume":"90","author":"A Machens","year":"2025","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Geospatial inheritance across the breath of the RET mutational landscape of multiple endocrine neoplasia 2A. Endocrine. 90, 1027\u20131034 (2025)","journal-title":"Endocrine"},{"key":"4567_CR36","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1210\/jc.2007-1714","volume":"93","author":"R Elisei","year":"2008","unstructured":"R. Elisei, B. Cosci, C. Romei, V. Bottici, G. Renzini, E. Molinaro, L. Agate, A. Vivaldi, P. Faviana, F. Basolo, P. Miccoli, P. Berti, F. Pacini, A. Pinchera, Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J. Clin. Endocrinol. Metab. 93, 682\u2013687 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.bjc.6605056","volume":"100","author":"MM Moura","year":"2009","unstructured":"M.M. Moura, B.M. Cavaco, A.E. Pinto, R. Domingues, J.R. Santos, M.O. Cid, M.J. Bugalho, V. Leite, Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas. Br. J. Cancer. 100, 1777\u20131783 (2009)","journal-title":"Br. J. Cancer"},{"key":"4567_CR38","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1089\/thy.2023.0110","volume":"33","author":"N Sahakian","year":"2023","unstructured":"N. Sahakian, P. Romanet, D. Mirebeau-Prunier, C. Paladino, F. Castinetti, A. Barlier, Letter to the editor: the somatic RET M918T variant may modify the natural history of germline RET L790F MEN2-related medullary thyroid carcinoma. Thyroid. 33, 1378\u20131379 (2023)","journal-title":"Thyroid"},{"key":"4567_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1210\/clinem\/dgac325","volume":"107","author":"R Elisei","year":"2022","unstructured":"R. Elisei, R. Ciampi, A. Matrone, A. Prete, C. Gambale, T. Ramone, G. Simeakis, G. Materazzi, L. Torregrossa, C. Ugolini, C. Romei, Somatic RET indels in sporadic medullary thyroid cancer: prevalence and response to selpercatinib. J. Clin. Endocrinol. Metab. 107, 2195\u20132202 (2022)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR40","doi-asserted-by":"publisher","first-page":"K43","DOI":"10.1093\/ejendo\/lvae025","volume":"190","author":"A Machens","year":"2024","unstructured":"A. Machens, H. Dralle, Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. Eur. J. Endocrinol. 190, K43\u2013K46 (2024)","journal-title":"Eur. J. Endocrinol."},{"key":"4567_CR41","doi-asserted-by":"publisher","first-page":"109549","DOI":"10.1016\/j.ejso.2024.109549","volume":"51","author":"A Machens","year":"2025","unstructured":"A. Machens, K. Lorenz, F. Weber, H. Dralle, Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancer. Eur. J. Surg. Oncol. 51, 109549 (2025)","journal-title":"Eur. J. Surg. Oncol."},{"key":"4567_CR42","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1210\/jc.2018-02102","volume":"104","author":"R Elisei","year":"2019","unstructured":"R. Elisei, A. Matrone, L. Valerio, E. Molinaro, L. Agate, V. Bottici, D. Viola, C. Giani, V. Cappagli, F. Latrofa, G. Materazzi, L. Torregrossa, C. Ugolini, F. Basolo, C. Romei, Fifty years after the first description, MEN 2B syndrome diagnosis is still late: descriptions of two recent cases. J. Clin. Endocrinol. Metab. 104, 2520\u20132526 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/418823a","volume":"418","author":"R Bernards","year":"2002","unstructured":"R. Bernards, R.A. Weinberg, A progression puzzle. Nature. 418, 823 (2002)","journal-title":"Nature"},{"key":"4567_CR44","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/EJE-21-0753","volume":"86","author":"RMB Maciel","year":"2022","unstructured":"R.M.B. Maciel, A.L. Maia, Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review. Eur. J. Endocrinol. 86, R15\u2013R30 (2022)","journal-title":"Eur. J. Endocrinol."},{"key":"4567_CR45","doi-asserted-by":"publisher","first-page":"E336","DOI":"10.1210\/jc.2012-3192","volume":"98","author":"A Machens","year":"2013","unstructured":"A. Machens, K. Lorenz, H. Dralle, Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening. J. Clin. Endocrinol. Metab. 98, E336\u2013E345 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4567_CR46","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","volume":"15","author":"F Castinetti","year":"2014","unstructured":"F. Castinetti, X.P. Qi, M.K. Walz, A.L. Maia, G. Sans\u00f3, M. Peczkowska, K. Hasse-Lazar, T.P. Links, S. Dvorakova, R.A. Toledo, C. Mian, M.J. Bugalho, N. Wohllk, O. Kollyukh, L. Canu, P. Loli, S.R. Bergmann, J. Biarnes Costa, O. Makay, A. Patocs, M. Pfeifer, N.S. Shah, T. Cuny, M. Brauckhoff, B. Bausch, E. von Dobschuetz, C. Letizia, M. Barczynski, M.K. Alevizaki, M. Czetwertynska, M.U. Ugurlu, G. Valk, J.T. Plukker, P. Sartorato, D.R. Siqueira, M. Barontini, M. Szperl, B. Jarzab, H.H. Verbeek, T. Zelinka, P. Vlcek, S.P. Toledo, F.L. Coutinho, M. Mannelli, M. Recasens, L. Demarquet, L. Petramala, S. Yaremchuk, D. Zabolotnyi, F. Schiavi, G. Opocher, K. Racz, A. Januszewicz, G. Weryha, J.F. Henry, T. Brue, B. Conte-Devolx, C. Eng, H.P. Neumann, Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet Oncol. 15, 648\u2013555 (2014)","journal-title":"Lancet Oncol."},{"key":"4567_CR47","doi-asserted-by":"publisher","first-page":"e734","DOI":"10.1210\/clinem\/dgad156","volume":"108","author":"A Machens","year":"2023","unstructured":"A. Machens, K. Lorenz, T. Brandenburg, D. F\u00fchrer-Sakel, F. Weber, H. Dralle, The changing face of multiple endocrine neoplasia 2A: from symptom-based to preventative medicine. J. Clin. Endocrinol. Metab. 108, e734\u2013e742 (2023)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04567-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:06:30Z","timestamp":1771272390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04567-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4567"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04567-x","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from each patient and\/or legal guardian as applicable before each\n                      RET\n                      gene test and each operation, all of which represented standard of care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"75"}}